MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 16.03.2026
Cue Biopharma Gesamtes Eigenkapital 2011-2026 | CUE
Gesamtes Eigenkapital Jährlich Cue Biopharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.4 M | 17.5 M | 37.1 M | 65.7 M | 65.5 M | 78.9 M | 54.6 M | 34 M | 61.6 M | 15.2 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 78.9 M | 15.2 M | 45.6 M |
Gesamtes Eigenkapital Vierteljährlich Cue Biopharma
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.2 M | 18.2 M | 17.5 M | 25.4 M | 21.6 M | 37.1 M | 42.7 M | 46 M | 55 M | 65.7 M | 50.8 M | 59.8 M | 64.7 M | 65.5 M | 63.5 M | 72.9 M | 69.7 M | 78.9 M | 78.9 M | 78.9 M | 78.9 M | 54.6 M | 54.6 M | 54.6 M | 54.6 M | 34 M | 34 M | 34 M | 34 M | 61.6 M | 61.6 M | 61.6 M | 61.6 M | 15.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 78.9 M | 13.2 M | 50.6 M |
Gesamtes Eigenkapital anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtes Eigenkapital | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Coherus BioSciences
CHRS
|
61 M | $ 1.71 | -0.29 % | $ 200 M |  USA |
 |
FSD Pharma
HUGE
|
5.1 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
621 M | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
24.3 M | - | 1.35 % | $ 17.8 M |  China |
 |
Milestone Pharmaceuticals
MIST
|
41.8 M | $ 1.72 | -9.47 % | $ 183 M | Canada |
 |
AgeX Therapeutics
AGE
|
-37 K | - | -10.17 % | $ 12.2 K | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
214 M | $ 8.26 | 0.12 % | $ 226 M |  Israel |
 |
I-Mab
IMAB
|
1.72 B | - | - | $ 866 M | China |
 |
vTv Therapeutics
VTVT
|
64.4 M | $ 31.67 | -1.39 % | $ 126 M | USA |
 |
Midatech Pharma plc
MTP
|
6.72 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
ImmuCell Corporation
ICCC
|
27.1 M | $ 8.36 | -0.24 % | $ 75.5 M | USA |
 |
Biophytis SA
BPTS
|
2.27 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
-16.2 M | - | 2.54 % | $ 160 B | France |
 |
Athira Pharma
ATHA
|
27.8 M | - | - | $ 269 M | USA |
 |
Esperion Therapeutics
ESPR
|
-302 M | $ 3.12 | -0.32 % | $ 649 M | USA |
 |
Exelixis
EXEL
|
2.16 B | $ 51.29 | 3.7 % | $ 13.9 B | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-14.6 M | - | 0.74 % | $ 768 M | Israel |
 |
Fortress Biotech
FBIO
|
49.9 M | $ 2.23 | -1.33 % | $ 62.2 M | USA |
 |
Forte Biosciences
FBRX
|
61 M | $ 24.66 | 1.52 % | $ 319 M | USA |
 |
AbCellera Biologics
ABCL
|
967 M | $ 4.77 | -3.64 % | $ 1.42 B | Canada |
 |
Amphastar Pharmaceuticals
AMPH
|
789 M | $ 18.32 | 4.69 % | $ 856 M | USA |
 |
BioNTech SE
BNTX
|
19.2 B | $ 92.23 | -1.53 % | $ 22.3 B | Germany |
 |
Genmab A/S
GMAB
|
36.7 B | $ 26.55 | -1.99 % | $ 1.72 B |  Danmark |
 |
Compugen Ltd.
CGEN
|
103 M | $ 2.85 | 0.71 % | $ 266 M | Israel |
 |
Checkmate Pharmaceuticals
CMPI
|
69.5 M | - | - | $ 231 M | USA |
 |
Grifols, S.A.
GRFS
|
8.61 B | $ 7.71 | 1.98 % | $ 5.24 B |  Spain |
|
Enlivex Therapeutics Ltd.
ENLV
|
1.93 B | $ 0.73 | -2.26 % | $ 33.4 M | Israel |
 |
Advaxis
ADXS
|
-24.4 M | - | -9.65 % | $ 45.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
5.59 M | $ 3.64 | 7.37 % | $ 5.99 M | Israel |
 |
Aeglea BioTherapeutics
AGLE
|
715 M | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
688 M | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
29.5 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
69.4 M | - | 1.93 % | $ 17.4 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
35.5 M | $ 6.77 | -3.7 % | $ 193 M | USA |
 |
Akero Therapeutics
AKRO
|
750 M | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
-27.2 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
38.3 M | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
234 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
176 M | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
78.8 M | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
169 M | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
189 M | $ 21.69 | 4.83 % | $ 2.76 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
18.9 M | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
3.36 M | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
60.8 M | - | - | $ 10.1 M | USA |
 |
Galectin Therapeutics
GALT
|
-128 M | $ 2.23 | -0.89 % | $ 143 M | USA |